Source: The Market Herald

Advance Pharma: Dimerix secures $10.7m upfront payment from Advanz Pharma

Biopharma company Dimerix (ASX:DXB) has received an initial upfront payment of €6.5...

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
500-1.0K
Steffen Wagner's photo - CEO of ADVANZ PHARMA

CEO

Steffen Wagner

CEO Approval Rating

82/100

Read more